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Abstract
Background: Pathological tremor is the most prevalent movement disorder. Current treatments do not attain a
signiﬁcant tremor reduction in a large proportion of patients, which makes tremor a major cause of loss of quality of
life. For instance, according to some estimates, 65% of those suﬀering from upper limb tremor report serious
diﬃculties during daily living. Therefore, novel forms for tremor management are required. Since muscles intrinsically
behave as a low pass ﬁlter, and tremor frequency is above that of volitional movements, the authors envisioned the
exploitation of these properties as a means of developing a novel treatment alternative. This treatment would rely on
muscle co-contraction for tremor management, similarly to the strategy employed by the intact central nervous
system to stabilize a limb during certain tasks.
Methods: We implemented a neuroprosthesis that regulated the level of muscle co-contraction by injecting current
at a pair of antagonists through transcutaneous neurostimulation. Co-contraction was adapted to the instantaneous
parameters of tremor, which were estimated from the raw recordings of a pair of solid state gyroscopes with a
purposely designed adaptive algorithm. For the experimental validation, we enrolled six patients suﬀering from
parkinsonian or essential tremor of diﬀerent severity, and evaluated the eﬀect of the neuroprosthesis during standard
tasks employed for neurological examination.
Results: The neuroprosthesis attained signiﬁcant attenuation of tremor (p < 0.001), and reduced its amplitude up to
a 52.33 ± 25.48%. Furthermore, it alleviated both essential and parkinsonian tremor in spite of their diﬀerent etiology
and symptomatology. Tremor severity was not a limiting factor on the performance of the neuroprosthesis, although
there was a subtle trend towards larger attenuation of more severe tremors. Tremor frequency was not altered during
neurostimulation, as expected from the central origin of Parkinson’s disease and essential tremor. All patients showed
a good tolerance to neurostimulation in terms of comfort and absence of pain, and some spontaneously reported
that they felt that tremor was reduced when the neuroprosthesis was activated.
Conclusions: The results presented herein demonstrate that the neuroprosthesis provides systematic attenuation of
the two major types of tremor, irrespectively from their severity. This study sets the basis for the validation of the
neuroprosthesis as an alternative, non-invasive means for tremor management.
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Background
Pathological tremors, understood as the ensemble of
tremors that are cause of functional disability, constitute
the most prevalent movement disorder. Although obtain-
ing an estimate of its prevalence is challenging [1], a recent
population study showed that tremor aﬀects 15% of those
with age ranging between 50 and 89 years [2]. Accord-
ing to some estimates, more than 65% of those who suﬀer
from pathological tremor—referred to as tremor in the
remainder of the paper—at the upper limb report serious
diﬃculties when performing their activities of daily living
(ADLs) [3]. Therefore, tremor has an enormous impact on
the independence and quality of life of many.
The two most relevant conditions, in terms of preva-
lence, that cause tremor are essential tremor (ET) and
Parkinson’s disease (PD). ET is believed to originate by
abnormal neuronal oscillations at the cerebellar and tha-
lamocortical pathways [4,5] and, according to some, con-
stitutes the most common movement disorder in adults
[1] (it aﬀects ∼ 5% of people over age 65 [6]). Much is yet
unknown about ET, for example there is still no consensus
on whether it is a neurodegenerative or non-degenerative
disease [7]. PD is a neurodegenerative disease that arises
from the death of dopaminergic nigrostriatal neurons,
causing abnormal oscillations in the loop linking the cor-
tex, basal ganglia and thalamus [8]. PD is estimated to
aﬄict more than ten million people all over the world
[9]. In addition to them, up to eight more syndromes
are acknowledged to cause tremor [10]. Importantly, no
tremor is yet fully understood [4], which hampers the
development of novel therapies, and the reﬁnement of the
existing ones.
Tremors are managed either through pharmacotherapy
or neurosurgery, the latter consisting in the implantation
of a deep brain stimulator (DBS), or the realization of ther-
apeutical lesions in deep brain structures (gamma knife
thalamotomy). Nonetheless, both pharmacotherapy and
neurosurgery carry drawbacks associated. Drugs often
induce side eﬀects [11,12], and show decreased eﬀective-
ness over years of use [13,14], while DBS is related to
increased risk of intracranial haemorrhage [15] and psy-
chiatric manifestations [16], and the percentage of eligible
patients is extremely low [17]. As for the tremors them-
selves, the mechanisms accounting for the alleviation of
their symptoms by these therapies are not fully elucidated.
Among the alternative approaches for tremor manage-
ment, the application of mechanical loads, either forces
or masses, is regarded as one of the most promising solu-
tions. A number of works show how adequate inertial
(mass) loading of the tremulous limb reduces the ampli-
tude of most types of tremor [18,19], and so does the
application of forces with certain characteristics. Force
loads typically consist of viscous ﬁelds [20,21], although
the eﬀect of added stiﬀness [22] and inertia [23] on tremor
has also been investigated. Furthermore, voluntary [24,25]
or artiﬁcially elicited [26] muscle contractions aﬀect the
severity of the tremor, by generating forces on the muscu-
loskeletal system.
These ﬁndings motivated the development of orthotic
devices for tremor attenuation, being the majority of them
wheel-chair mounted [27,28] or ﬁxed to an external frame
[29,30]. To the best of our knowledge, the only ambula-
tory system for tremor attenuation through mechanical
loading extensively validated with patients is the wearable
robotWOTAS [21]. This system attained consistent atten-
uation of tremors over a certain severity but, however,
did not fulﬁll users’ expectations in terms of cosmetics
and aesthetics [21]. Besides, it was found that the intrin-
sic diﬃculty of transmitting external forces to the skeletal
system through the soft tissues hampered the improve-
ment of solutions of this kind. Therefore, here we present
a novel approach for tremor management aimed at cir-
cumventing these limitations. Our novel solution consists
of a neuroprosthesis (NP) that applies forces to the tremu-
lous limb through transcutaneous neurostimulation. We
show that by co-contracting the aﬀected muscles it is
possible to alter the inherent low pass ﬁlter properties
of human muscles [31] and attenuate the tremor, with-
out aﬀecting the concomitant voluntary movement. Our
results demonstrate that the NP provides systematic alle-
viation of tremors of diﬀerent etiology and characteristics,
avoiding discomfort and pain. Notice that transcutaneous
neurostimulation for tremor management had been pre-
liminarily evaluated in [32]. There, an alternanting stim-
ulation pattern that opposed the tremor activation bursts
was employed to reduce its severity [26]. The system was,
however, table mounted.
This paper is organized as follows. First, we describe
the NP and the controller it implements, together with
the experimental protocol and methods employed for its
validation. Afterwards, we review and discuss the results
achieved. The manuscript ends up with conclusions sum-
marizing the outcomes of the study.
Methods
The neuroprosthesis for tremor management
The NP here presented employed transcutaneous neu-
rostimulation to apply mechanical loads as a means of
alleviating upper limb tremor. Loads were applied concur-
rently at a pair of antagonist muscles—in co-contraction—
in such a way that joint impedance was adequately manip-
ulated. The elicited co-contraction level was continuously
adapted to the ongoing severity of the tremor, which
was estimated from the recordings of solid state gyro-
scopes. Figure 1(A) shows the concept design we fol-
lowed. The NP actuated at the wrist and elbow joints,
because they have the largest impact on disability [33], and
took the shape of a textile substrate that integrated the
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Figure 1 NP for tremor management. The concept design (A) envisioned the NP as a textile substrate that integrated the neurostimulation
electrodes, the gyroscopes and the control electronics. The ﬁnal prototype (B) consisted of two pairs of textile supports that incorporated the solid
gyroscopes, and oﬀ the shelf transcutaneous electrodes. This permitted personalizing the prototype to each patient. In (B), red arrows point at the
gyroscopes (placed in the textile supports), and blue arrows at the neurostimulation electrodes (the color code corresponds to that employed for
the NP constituents in (A)). The electrodes over the ﬂexor carpi ulnaris and the biceps brachii are not visible in the picture.
neurostimulation electrodes and the sensors that drove
the system. The textile substrate could be worn under-
neath the clothes, thus satisfying users’ expectations in
terms of cosmetics and usability. Figure 1(B) shows a
patient wearing the ﬁnal prototype, which had modular
design (it was not a continuous garment as represented in
the concept) in order to maximize its adaptability to user’s
anatomy.
The rationale behind the use of co-contraction was to
increase simultaneously the stiﬀness and viscosity of the
tremulous limb, which in turn would decrease the cut-
oﬀ frequency (∼ 2–3 Hz [31,32,34]) of the inherent low
pass ﬁlter response of muscles, ﬁltering out the tremor.
Indeed, co-contraction is exploited by the intact central
nervous system to stabilize the limbs during speciﬁc tasks
[35,36]. Furthermore, this could be implemented directly
by increasing muscle activation, because stiﬀness and vis-
cosity are monotonic functions of the contraction level
[37].
A simpliﬁed explanation of our approach is given next.
Equation (1) represents a human joint with the NP
attached to it. There, the human joint was modeled as
a second order linear time invariant system (as done in
many works in the literature, e.g. [30,31,38]), while the
NP was represented as a variable stiﬀness and viscosity,
according to what was explained before. Given that the
NP behaves as a system acting in parallel to the limb, the
resultant response could be modeled as [30,38]:
θ(s)
T(s) =
G
Is2 + (D + DNP)s + (K + KNP) (1)
where θ(s) is the tremulous component of movement
(estimated as described in epigraph ‘Tremor Parameter-
ization’), T(s) represents the torque that generates the
tremor, I,D, and K stand for the inertia, viscosity and stiﬀ-
ness of the joint respectively, and G is the magnitude of
the response of the resultant system (that is function of its
mechanical parameters). The viscosity and stiﬀness added
by the NP as a result of increased muscle contraction are
denoted by DNP and KNP, and satisfy DNP,KNP ≥ 0, being
DNP,KNP = 0 if the NP was not activated.
Given that the analytical expression that relates the
changes in DNP and KNP caused by the NP to the cut
oﬀ frequency of the resultant system (represented in (1))
is very complex, in Figure 2 we show how a concur-
rent increase DNP and KNP would aﬀect the frequency
response of the joint. There, it is displayed how the cut
oﬀ frequency would be decreased in a nonlinear manner
when the contraction level, and thus the resultant stiﬀ-
ness,K+KNP, and viscosity,D+DNP, of the joint [37], were
increased. The change in the magnitude of the response
observed in Figure 2 illustrates how co-contraction stabi-
lizes the limb, as reported in the literature [35,36].
In our case, the level of artiﬁcially elicited
co-contraction was adapted to the characteristics—
instantaneous amplitude and frequency—of the tremor.
An independent controller was implemented for each
joint, because the characteristics of tremor diﬀers among
them, and show a non-stationary behavior that is nor-
mally uncoupled. Neurostimulation was controlled as
follows. Tremor frequency deﬁned when the control
output was to be updated, while tremor amplitude mod-
ulated the amount of current to be injected to each
muscle. Tremor parameters estimated during a (tremor)
period were employed to generate the control action in
the subsequent one, analogously to repetitive control
theory [40]. This provided the controller with a certain
predictive nature. The reason to modulate the level of
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Figure 2 Rationale behind the tremor suppression approach.
Frequency response of a human joint, showing how it is modiﬁed by
co-contraction of the antagonist muscle pair. The data for the human
joint without the neuroprosthesis (black trace) corresponds to the
model given in (1) ﬁtted to the parameters identiﬁed for the wrist in
[39]. The remainder traces represent how the response of the joint is
modiﬁed by a concurrent increase in viscosity and stiﬀness (deﬁned
as a multiple of the parameters D and K), and correspond to: i) equal
increments of DNP and KNP (in multiples of 10, from 10 to 100, shown
as blue traces), ii) larger increments of DNP (in multiples of 50, from 50
to 500) than of KNP (in multiples of 10, from 10 to 100, shown as red
traces), and iii) larger increments of KNP (in multiples of 50, from 50 to
500) than of DNP (in multiples of 10, from 10 to 100, shown as yellow
traces). For all cases, larger values of DNP and KNP cause the response
of the joint to have smaller magnitude (as indicated by the arrow in
gray).
neurostimulation independently for each muscle in the
pair of antagonists was twofold: ﬁrst, because of their dif-
ferent electrophysiological response to neurostimulation,
and second, because this response also varies with time
in a diﬀerent manner for each muscle. Neurostimulation
was modulated in amplitude; current frequency and pulse
width were kept constant. Details on the adaptive ﬁlter
employed to estimate instantaneous tremor amplitude
and frequency, and on the control algorithm, are given
next.
Tremor parameterization
Joint rotation was simply obtained by computing the dif-
ference of a pair of solid state gyroscopes, which were
located at the distal and proximal segments following [41].
Next, given that the concomitant voluntary and tremulous
movements are additive [42], the total joint rotation y(k)
measured at each joint was expressed as:
y(k) = ytremor(k) + yvol(k) (2)
where ytremor(k) represents the tremor, and yvol(k) the
component of voluntary movement. A two–stage ﬁl-
ter [42], summarized next, separated the voluntary
movement and the tremor in order to estimate the
instantaneous parameters of the latter. This information
was in turn employed by the controller to drive the
NP.
The estimation of voluntary movement relied on the
fact that tremors occur at a higher frequency (in the 3–
12 Hz band [10]) than that employed to perform the ADL
(below 2 Hz [43]). Therefore, concomitant tremulous and
voluntary components of movement were separated (in
the ﬁrst stage) based solely on their diﬀerent frequency
bands. This was implemented with a g − h ﬁlter [44] that
estimated the voluntary component of motion. The g − h
ﬁlter is an adaptive algorithm that incorporates a ﬁrst
order model of voluntary movement, and is formulated as
follows:
xk,k = xk,k−1 + gk(yk − xk,k−1) (3)
x˙k,k = x˙k,k−1 + hkTs (yk − xk,k−1) (4)
xk+1,k = xk,k + Ts x˙k,k (5)
x˙k+1,k = x˙k,k (6)
where xk,k and x˙k,k represent the estimation of voluntary
movement and its derivative, which were computed in (3)
and (4) by updating the previous predictions xk,k−1 and
x˙k,k−1 with the current measurement yk . Equations (5)
and (6) predicted the future value of the voluntary move-
ment and its derivative,xk+1,k and x˙k+1,k , based on the ﬁrst
order model included in the ﬁlter; Ts represents the sam-
pling period. Filter parameters gk and hk were considered
to be constant, and chosen so that they fulﬁll the next
relationship, which minimizes the squared error of pre-
vious measurements assigning less signiﬁcance to older
values [44]:
g = 1 − θ2 (7)
h = (1 − θ)2
By selecting an adequate value of parameter θ we
obtained a precise estimation of voluntary movement
with negligible delay, which is of foremost importance
to get an accurate tracking of tremor parameters. The
delay introduced by Butterworth, Chebyshev and elliptic
low pass ﬁlters was notably higher, which motivated our
choice.
Instantaneous tremor frequency and amplitude were
subsequently estimated (in the second stage) with a
Weighted Frequency Fourier Linear Combiner (WFLC)
[45] and a Kalman Filter [46] in the following man-
ner: the WFLC tracked tremor frequency, and this
value was fed into the Kalman ﬁlter, which estimated
the instantaneous amplitude of tremor. This cascade
architecture permited optimizing the tracking of both
parameters [45].
The WFLC adapts concurrently the amplitude terms
and fundamental frequency of a truncated Fourier series
based on the Least Mean Squares recursion [45]. Our
Kalman ﬁlter also implemented a ﬁrst order harmonic
Gallego et al. Journal of NeuroEngineering and Rehabilitation 2013, 10:36 Page 5 of 12
http://www.jneuroengrehab.com/content/10/1/36
representation of the tremor, and was formulated as
follows:⎡
⎣ Ak,k−1Bk,k−1
trk,k−1
⎤
⎦ =
⎡
⎣ 1 0 00 1 0
cos(
∑
t ωt) sin(
∑
t ωt) 0
⎤
⎦
⎡
⎣ Ak−1,k−1Bk−1,k−1
trk−1,k−1
⎤
⎦
(8)
ytremor,k = trk,k−1 (9)
where A and B are the amplitude terms of the Fourier
series, and ωt is the instantaneous frequency derived with
the WFLC; trk,k−1 represents the estimation of tremor
based on these three parameters. Measurement noise
covariance was deﬁned as R(k) = σ 2τ , whereas process
noise Q(k) was modeled as a diagonal matrix, assum-
ing independence of the state variables. The measurement
noise covariance was related to the accuracy of the esti-
mation of ytremor,k with the g − h ﬁlter, while the process
noise covariance determined the adaptation rate of the
amplitude terms of the truncated Fourier series, A and B.
Control algorithm
The controller that regulated neurostimulation amplitude
was a rule-based proportional-integral law (10), where the
integral gain was switched between two values depending
on the amplitude of the residual tremor (11). By switching
the value of Ki(trk,k−1) to 0, the controller neglected the
integral term when the amplitude of the tremor was small,
i.e. below the threshold thint gain, which avoided possi-
ble unnecessary periods of stimulation when the tremor
was very mild and did not pose a functional problem.
Furthermore, the integral was reset when tremor ampli-
tude decreased below a certain threshold, thint reset . This
avoided adding the residual tremor to the integrator when
tremor amplitude was very small, which prevented brisk
transients if the tremor developed again. The inclusion
of a integral term was very important to compensate
for the time varying response to neurostimulation that
characterizes this type of applications, which manifests
overall in terms of muscle fatigue and accommodation to
neurostimulation [47]. The controller was deﬁned as:
uk = Kptrk,k−1 + Ki(trk,k−1)
k∑
j=1
trjTs (10)
Ki(trk,k−1) =
{
Ki if trk,k−1 ≥ thint gain
0 if trk,k−1 < thint gain
(11)
where Kp and Ki(trk,k−1), are the controller gains (the
value of the latter was switched depending on tremor
amplitude, as shown in (11)), and u(k) the control
action. Importantly, a saturation was applied to u(k) in
order to limit the electrical charge injected to the mus-
cle. This value was deﬁned for each muscle during a
calibration phase.
The NP was triggered when the onset of tremor and
its initial frequency were detected from the solid state
gyroscopes. Tremor onset was immediately obtained by
comparing the estimated tremor amplitude, trk,k−1, to a
threshold, trth. A gross estimation of tremor frequency
was computed as the maximum of the amplitude spec-
trum in the 3–12 Hz band [10]. This estimation was used
to initialize the WFLC. In order to double-check tremor
detection, we used the following criterion that relied on
the spectral characteristics of the total movement: if the
ratio of tremor to voluntary movement (TVR) was larger
than a certain value deﬁned manually (TVRth), we consid-
ered that the spectrum reﬂected the presence of tremor.
In case this condition was not fulﬁlled, the next window
of equal length was employed for the calculation; 50%
overlapping was allowed. The TVR was deﬁned as:
TVR =
∑f=12
f=3 Xf∑f=3
f=0 Xf
(12)
where
∑f=3
f=0 Xf and
∑f=12
f=3 Xf represent the integral of
the amplitude spectrum in the 0–3Hz and 3–12Hz bands.
Similar ratios have been employed in other works about
tremor, e.g. for EMG analysis [48].
Patients, apparatus and experimental protocol
We present results obtained by evaluating the NP
in 6 patients (1 female) suﬀering from either PD (n
= 2) or ET (n = 4). Average age was 68.2 ± 13.8
years. Tremor amplitude, according to neurological rat-
ing, ranged from very mild to severe (from 3 to 30
according to Fahn-Tolosa-Marin scorea [49]). ET patients
were asked to interrupt their intake of medication 24
h before the recordings, while PD patients continued
the use of antiparkinsonian medication. All patients
signed a written informed consent to participate. The
protocol was approved by the Polytechnic University
of Valencia, which warranted its accordance with the
Declaration of Helsinki. Details on patients are given
in Table 1.
Patients wore the NP at the most aﬀected side and were
asked to perform the clinical task that made their tremor
more evident. Typical exercises for neurological examina-
tion were considered: resting the arm on the lap, keeping
both arms outstretched, the ﬁnger to ﬁnger test, and the
ﬁnger to nose test [10]. Patients were sitting in a comfort-
able armchair during the whole session. The NP recorded
both wrist ﬂexion/extension and elbow ﬂexion/extension
with two pairs of solid state gyroscopes (Technaid S.L.,
Madrid, Spain), although we present results only for the
wrist, because it was where the tremor was visible for
all patients. Neurostimulation was delivered at the ﬂexor
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Table 1 Details of patients
Patient Disorder Gender Age Tremor frequency (Hz) Tremor severity
01 ET M 69 ∼ 4.2 27
02 PD M 44 ∼ 3.5 30
03 ET M 82 ∼ 5.1 n.a. (moderate)
04 PD M 67 ∼ 4.8 3
05 ET F 66 ∼ 4.5 17
06 ET M 81 ∼ 8.0 n.a. (mild)
carpi ulnaris and extensor carpi radialis with a multichan-
nel monopolar neurostimulator with charge compensated
pulses (UNA Systems, Belgrade, Serbia); the common
electrode was located at either the dorsal or volar side
of the wrist. Maximum neurostimulation amplitude for
each muscle was personalized during an initial calibration
phase; pulse width and frequency were set to either 300
μs and 40 pps or 250 μs and 30 pps respectively, depend-
ing on the patient: we used the ﬁrst combination of values
in patients that needed high current density to elicit a vis-
ible muscle contraction. The controller was implemented
in a stand alone computer (QNX Software Systems,
Ontario, Canada). Figure 1(B) shows a patient wearing
the NP.
Each patient performed a number of repetitions of two
types of trials; the duration of each was 30 s. The ﬁrst
type of trial consisted of two 15 s sub-periods, during
the second of which the NP was activated. In the sec-
ond type of trial, the NP was never activated. This type
of trial was included in the protocol to avoid a possi-
ble distortion of the study due to, for example, a natu-
ral reduction of tremor amplitude over time. Both types
were randomized, and the experimental design was bal-
anced using an optimal algorithm, in which the repeti-
tions were ordered by concatenating latin squares [50]. In
total, each patient performed between 6 and 12 repeti-
tions. Patients with mild or moderate tremor were asked
to count mentally backwards during the experiments to
exacerbate their tremor [51,52], and the two with PD
counted out loud at the beginning of the session as rec-
ommended in [52]. Patients with severe or very persistent
tremor were not asked to count during the recordings to
avoid excessive mental stress, which could have possible
ethical implications.
Data analysis
To quantify the eﬀect of the NP on tremor amplitude,
we computed the ratio Ratt of the integral of the power
spectral density of the tremor during the part of the trial
with co-contraction, to the same variable without it [21].
Before, data were split into 1 s non-overlapping windows
to minimize the eﬀects of eventual non-stationarities, and
zero padded; Ratt was calculated with the median values
for both conditions. We computed Ratt also for the trials
during which the NP was not activated, in order to inves-
tigate whether it had a real eﬀect on the tremor. To this
end, we considered equivalent periods for its calculation.
We assessed whether the NP had a real eﬀect on
tremor amplitude by comparing Ratt in the ensemble
of trials of the two types (pooled trials in which these
NP was activated or not) with a Mann-Whitney test,
given that the pooled datasets did not conform nor-
mality after transformation (Kolmogorov-Smirnov test,
p < 0.05). We also evaluated whether there was
an eﬀect on tremor frequency with a Mann-Whitney
test. Throughout the paper, values are reported as
mean ± SD.
The parameters for the tremor parameterization algo-
rithms and the controller were set to: i) for the g − h
ﬁlter, θ = 0.900, ii) for the Kalman ﬁlter, σ 2τ = 0.01,
Q(k) = diag(1, 1, 0), and iii) for the WFLC, μ0 =
0.001, μ1 = 0.01, μb = 0.01, M = 1, f0 was initialized
to the value computed from the amplitude spectrum at
tremor onset (data epoch of 2 s with zero padding). The
parameters of these three algorithms were obtained by
analyzing oﬄine a previously recorded dataset. Controller
gains were selected manually based on the amplitude of
the tremor that was observed during calibration and the
required neurostimulation amplitude. During this phase,
we also deﬁned the saturation level (maximum current
amplitude) the controller could deliver at each muscle.
Thresholds for tremor onset, frequency estimation, inte-
gral reset, and gain switching were trth = 0.1 rad/s,
TVRth = 3, thint reset = 0.1 rad/s, and thint gain = 0.1 rad/s.
Results and discusison
Results
Figure 3 shows a typical example of the performance
of the NP, representing the current amplitude delivered
at each muscle together with the ongoing tremor (esti-
mated with the two-stage algorithm presented in epigraph
’Tremor Paramenterization’).We observe that∼ 2.5 s after
the system was triggered, the amplitude of the tremor
was drastically reduced, and the control action dimin-
ished and became 0. In the case of this patient, low cur-
rent kept the limb considerably stabilized, i.e. prevented
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Figure 3 Example of the controller of the NP. The plot shows the
estimation of tremor (solid line) and the amplitude of the current
applied at the extensors (dashed line) and ﬂexors (dotted line). The
instant at which the NP was triggered is signaled with an arrow.
Angular velocity is scaled [x 15] for visualization sake; a positive value
corresponds to wrist extension.
the tremor from reappearing with the same amplitude
that he normally exhibited. The importance of the inte-
gral term is appreciated at time ∼ 19 s at the ﬂexors,
when the controller maintained the maximum (satura-
tion) current amplitude to compensate for the still severe
tremor. In Figure 4 we show a representative example
of tremor alleviation with the NP for each patient, in
the time and frequency domains. They range from very
large attenuation (see Figure 4(B) and 4(E)) to mild reduc-
tion of tremor amplitude (see Figure 4(C)). Additional
ﬁle 1 provides two video examples of the performance of
the NP.
Figure 5 summarizes the eﬀect of the NP on tremor
amplitude for all the trials in which it was activated, and
shows that a consistent reduction was achieved (in 26 out
of 30 trials). Overall, tremor amplitude was reduced to a
Ratt = 52.33 ± 25.48%. The eﬀect of the NP on tremor
amplitude was found to be statistically signiﬁcant (p <
0.001) when compared to the trials in which it was not
activated. The large SD of the overall results originated
from the intrinsic variability of the patients’ symptoms,
as shown by how widespread the trials performed by the
same patients are in the abscissa of Figure 5. Furthermore,
more severe tremors were attenuated to a greater extent
(p = 0.008, Mann-Whitney test between the trials with
smallest and largest amplitude before the NP was acti-
vated). The slope of the linear ﬁt to the attenuation data in
Figure 5 (both axes log transformed) was −0.160, which
conﬁrmed this trend (R2 = 0.243).
Tremor was exacerbated (Ratt > 100) by the NP in
4 trials, 3 of which corresponded to those in which
patients 04 and 05 exhibited a tremor with lower ampli-
tude than observed during calibration (see Figure 6).
Given that controller gains were selected manually, and
that Ki(trk,k−1) was typically chosen to be smaller than
Kp, we believe that tremor exacerbation could be over-
come by improving this method. In the remaining trial,
tremor amplitude augmented because the patient’s mus-
cles suﬀered from accommodation to neurostimulation
[47]. Two evidences supported this statement: i) this was
the last trial of the session, and in the previous ones
the patient exhibited very large tremor attenuation (aver-
age reduction of tremor amplitude was Ratt = 26.79 ±
13.13%, Figure 5 details all the trials), and ii) the con-
troller applied the maximum current amplitude and did
not alleviate the tremor, on the contrary to previous rep-
etitions. However, notice that the performance of the
NP was not visibly inﬂuenced by trial order, as shown
in Figure 6.
Finally, we analyzed whether tremor attenuation with
the NP altered tremor frequency. By comparing tremor
frequency with and without the NP activated (for each
patient), we observed that it had no eﬀect on tremor fre-
quency (p = 0.831, see Figure 7), as expected from the
central origin of tremor in PD and ET.
Discussion
These results demonstrate that the NP here presented
constitutes a feasible approach to tremor management.
Through the control of muscle co-contraction, the NP
systematically alleviated the tremor independently from
its characteristics, proving that such approach is a viable
alternative for treating upper limb tremor. Interestingly,
all patients reported that the sensation generated by the
NP was tolerable and not unpleasant, and the overall
impression was that they could habituate to it. Further-
more, a few patients spontaneously declared that when
the NP was activated they could control better their
limbs. Users’ perception of the prototype was generally
good, and remarkably better than for previous robotic
devices.
The NP attained a reduction of tremor amplitude in
patients suﬀering both from PD and ET, in spite of
their inherent diﬀerences in underlying pathophysiologic
mechanisms [4] and symptomatology. Our initial con-
cern was that joint rigidity arising from PD [8] could
hinder tremor reduction with the NP in these patients,
given that their joints already show increased stiﬀness
and viscosity [53]. The physical reason for this would be
a displacement of the natural cut oﬀ frequency of their
muscles towards lower values (for healthy individuals it
is in the range ∼ 2–3 Hz [31,32,34]), which could in
turn impede attaining the level of co-contraction neces-
sary to attenuate the tremor. However, our results deemed
this hypothesis untrue, even in a patient with severe
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Figure 4 Examples of reduction of tremor amplitude with the NP. Each subplot in this graphic shows a representative trial for each patient, and
compares the amplitude of the tremor before (gray) and after (black) the NP was activated. Top plots represent the data in the time domain,
whereas bottom plots represent the same data in the frequency domain (we show the mean power spectral density for the neurostimulation and
non-neurostimulation periods). In the time domain, the moments at which the NP was triggered are signaled with an arrow; in the frequency
domain, the arrow points at the tremor peak while the NP was activated. Examples correspond to: patient 01 (A), patient 02 (B), patient 03 (C),
patient 04 (D), patient 05 (E) and patient 06 (F).
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Figure 5 Summary of all the trials in which the NP was active.
The plot shows tremor attenuation computed with Ratt as a function
of tremor severity. Each marker stands for a single trial. The plot is
interpreted as the further below the dashed line (geometrical locus of
Ratt = 100%), the larger the attenuation. Patients are codiﬁed as
follows:  corresponds to patient 01, to patient 02, + to patient 03,
◦ to patient 04, ♦ to patient 05, and  to patient 06.
parkinsonian tremor of low frequency (patient 02, who
had a tremor frequency of ∼ 3.5 Hz and experienced a
tremor reduction with the NP of Ratt = 26.79 ± 13.13%).
We believe that the eﬀects of levodopa intake might
have facilitated this by decreasing limb rigidity. The fact
that the NP successfully alleviated low frequency tremors
is of great interest, as the frequency of both essential
and parkinsonian tremor experience a decline with time
[54], and thus broadens the group of potential users of
the system.
In this line, tremor frequency did not to inﬂuence the
performance of the NP, although our group was biased to
patients suﬀering from low or medium frequency tremor
(below∼ 5 Hz, see Table 1). This characteristic was a con-
sequence of our patient selection because: i) we included
two patients suﬀering from PD, which tremor frequency
is typically below 6 Hz [10], and ii) the severity of ET is
inversely correlated with its frequency (the slope between
the log displacement and the log amplitude is ∼ −4
[55]), and our group comprised two subjects with moder-
ate and one with severe tremor (patients 01, 03 and 05).
Nevertheless, the performance of the NP for the patient
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Figure 6 Tremor attenuation as function of the trial number. The
plot shows how tremor attenuation computed with Ratt varied as
more trials were performed, for all patients. Each marker represents a
single trial, and the color of the marker corresponds to the severity of
the tremor during this trial (before the NP was activated). The color
scale is adjusted to the amplitude of each patient’s tremor, and
represents trials with mild tremor as cold colors, and with severe
tremor as hot colors (see colorbar in the plot). Patients are codiﬁed as
follows:  corresponds to patient 01, to patient 02, + to patient 03,
◦ to patient 04, ♦ to patient 05, and  to patient 06.
with high frequency tremor (patient 06) was good, achiev-
ing an attenuation of Ratt = 34.45 ± 8.87%. Although
this patient exhibited tremor which amplitude decayed
over time (Ratt = 77.35 ± 29.37% when the NP was not
active), the improvement with the NP was clearly notice-
able when both conditions are compared. Furthermore,
it was not clear a priori whether the NP could attenuate
low frequency tremors due to the fact that they mani-
fest close to the natural cut oﬀ frequency of muscles, and
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3
5
7
9
tre
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Figure 7 Eﬀect of the NP on tremor frequency. The plot compares
tremor frequency with the NP activated (black) and not activated
(gray) for each patient (denoted as PXX, where XX is the patient
code). Results are shown as mean (circle) ± SD (whiskers) of the mean
frequency for the ensemble of all trials.
thus require from a larger alteration of their physiologic
response. Given that average attenuation for patient 02
(tremor frequency ∼ 3.5 Hz) was Ratt = 26.79 ± 13.13%,
and for patient 01 (tremor frequency ∼ 4.2 Hz) was
Ratt = 58.99 ± 26.81%, we conclude that low frequency
tremors can be successfully managed with the NP. These
results suggest that tremor frequency is not a criterion
that restricts the applicability of the system.
As shown in Figure 7, the NP did not alter tremor
frequency in spite of the obvious proprioceptive feed-
back. This is motivated by the central origin of tremor in
PD [8] and ET [4,5], which predominates over the other
mechanisms that contribute to their genesis, namely long
and short latency reﬂexes, and mechanical factors [56].
Therefore, our results are in line with evidences on the
limited role of sensory feedback in the generation, main-
tenance and modulation of tremor in PD [8]. ET patients
however, exhibit a more evident interaction between the
stretch reﬂex and the tremor itself [22], being the most
noticeable example the separation of both components,
otherwise entrained, under inertial loading [57]. In this
line, visual inspection of Figure 4(F) (bottom plot, the
power spectral density) suggests that the central and reﬂex
components were separated in patient 06, both when the
NP was activated and not. A more profound investigation
of this phenomenon is needed, and would require from
the integration of electromyographic (EMG) recordings
and advanced signal processing techniques—to remove
the artifacts generated by the NP on the EMG signal—in a
novel protocol.
Furthermore, given that the NP implements a pro-
portional integral controller, our results suggest that an
increase in tremor amplitude was compensated by an
increase in the level of muscle co-contraction. As a conse-
quence, we can conjecture that both essential and parkin-
sonian tremor are reduced when muscle contraction is
suﬃciently augmented, i.e. when the stiﬀness and viscosity
of the tremulous joint are increased due to their mono-
tonic relationship with the activation level [37]. Compar-
ing this with previous works that assessed the inﬂuence of
voluntary muscle contraction on the amplitude of tremor,
our results are in line with what has been reported for
PD [24], but contradicts a recent study that showed how
high contraction intensities caused larger amplitude ﬂuc-
tuations in ET [25]. Remarkably, these studies assessed
the eﬀect of volitional muscle activation on tremor, while
ours deals with artiﬁcial activation with a NP, and thus
motor control mechanisms are involved in a lesser extent.
Therefore, we believe that the pathophysiologic land-
marks of PD and ET may account for the diﬀerence.
Although the cerebellothalamic pathways play a role in the
generation of parkinsonian symptoms [58], no evidence
of cerebellar involvement apart from a compensative
hyperactivation [59]—increased as the disease progresses
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[60]—, has been found. As for ET, on the contrary, all
three cerebellar areas are impaired to a certain extent [7].
Thus we believe that cerebellar disfunction could explain
the exacerbation of ET during voluntary contractions,
possibly through reticulospinal projections to muscles
[61,62].
In a few trials, we observed that tremor migrated
towards proximal joints when it was suppressed at the
more distal ones; i.e. when it was suppressed at the wrist
it appeared or increased at the elbow or at the shoul-
der. This occurred in patients with both PD and ET,
and has been previously reported in two studies deal-
ing with inertial or force loading in tremor. The ﬁrst
was a study on coordination during postural holding in
PD, where the authors found that mass loading of the
index ﬁnger enhanced the tremor at the proximal seg-
ments while posture was maintained [63]. The second
focused on the attenuation of tremors of diﬀerent eti-
ology (mainly ET) with a wearable robot that applied
a constant viscosity to the aﬀected joints [21]. None of
them found a detailed physiologic explanation for tremor
migration. Therefore, further research on this topic is
needed, given that it constitutes a major aspect when
developing NPs or neurorobots for functional compensa-
tion of tremor during daily living. Future studies will need
to address both the coordination mechanisms per se, and
the inﬂuence that inertial loads andmuscle activation have
on them.
When compared with current treatments for ET, the
reduction of tremor provided by the NP (Ratt = 50.37 ±
29.01%) was similar to that of drugs with proved eﬃ-
cacy (∼ 50% [12]), but worse than the results attained
with DBS (tremor attenuation ∼ 50 – 80%, [64]). Nev-
ertheless, the latter implies a surgical procedure, while
the NP is envisioned as a mock up system that the user
may wear underneath his clothes. Furthermore, when
compared to pharmacotherapy, the NP reduced tremor
amplitude in all 4 ET patients in our group, while drugs
are eﬀective in ∼ 50% of patients [65]. No conclusive
results can be drawn given the size of our group, although
this ﬁnding is encouraging. The 2 patients with PD con-
tinued their intake of levodopa during the experiments
but experienced a reduction of their tremor (Ratt =
42.56 ± 24.91%). This suggests that for these patients
the NP was an interesting approach to complement
pharmacotherapy.
Finally, the limitations of our study need to be acknowl-
edged. First, although our results demonstrate that the NP
constitutes a feasible alternative to tremor management,
we believe they may be improved by developing an auto-
matic method to select the gains of the controller. This
would require the identiﬁcation of the parameters of a
model of muscle response to stimulation, which consti-
tutes our future work. As mentioned above, we believe
that better gain selection could have eliminated most tri-
als with tremor exacerbation. Second, for extended use of
the NP, it would be necessary to adapt the parameters of
the controller when the muscle exhibits accommodation
to the ongoing level of neurostimulation. Manual tuning
of the parameters by a practitioner, together with adaptive
control techniques may provide a solution for this.
Conclusions
This study presented the design, implementation and vali-
dation of a novel NP for tremor management. Experimen-
tal results with a representative group of patients (mean
reduction of tremor amplitude Ratt = 52.33±25.48%, p <
0.001) proved the concept of tremor attenuation through
modulation of muscle co-contraction with an ambula-
tory NP. Importantly, consistent tremor attenuation was
achieved irrespectively from its severity, frequency, and
etiology (validation was performed with patients suﬀer-
ing from ET or PD), although there was a trend towards
greater reduction of more severe tremors. Importantly,
the patients found the sensation induced by the NP not
unpleasant, and informed that they could use it dur-
ing daily living. Furthermore, some of them reported
spontaneously that they felt that tremor was reduced
when the NP was activated. All patients exhibited a
positive response to the NP, which is of great interest
given that a signiﬁcant proportion of those suﬀering from
tremor do not respond to medication (e.g., 50% of ET
patients). These results encourage the functional and clin-
ical evaluation of the NP as a non invasive alternative to
tremor treatment, either alone, or as a complement to
pharmacotherapy.
Endnote
aThis rating only included those items related to tremor
severity at the most aﬀected limb.
Additional ﬁle
Additional ﬁle 1: Video that illustrates the performance of the NP. It
shows, for two patients (patients 01 and 02), how tremor amplitude within
a trial was remarkably reduced when the NP was activated.
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